121 related articles for article (PubMed ID: 8301565)
1. Enhancement of noradrenaline release from rat frontal cortex by thyrotropin releasing hormone and its analog, (3R,6R)-6-methyl-5-oxo-3-thiomorpholinylcarbonyl-L-histidyl-L-prolinami de, as studied by intracerebral microdialysis.
Itoh Y; Ogasawara T; Yamazaki A; Ukai Y; Miura A; Kimura K
J Pharmacol Exp Ther; 1994 Jan; 268(1):255-61. PubMed ID: 8301565
[TBL] [Abstract][Full Text] [Related]
2. Effect of NS-3, a thyrotropin-releasing hormone analog, on in vivo acetylcholine release in rat brain: regional differences and its sites of action.
Itoh Y; Ogasawara T; Mushiroi T; yamazaki A; Ukai Y; Kimura K
J Pharmacol Exp Ther; 1994 Nov; 271(2):884-90. PubMed ID: 7965809
[TBL] [Abstract][Full Text] [Related]
3. Effects of a novel thyrotropin-releasing hormone analogue, JTP-2942, on extracellular acetylcholine and choline levels in the rat frontal cortex and hippocampus.
Toide K; Shinoda M; Takase M; Iwata K; Yoshida H
Eur J Pharmacol; 1993 Mar; 233(1):21-8. PubMed ID: 8472746
[TBL] [Abstract][Full Text] [Related]
4. Effects of taltirelin hydrate (TA-0910), a novel thyrotropin-releasing hormone analog, on in vivo dopamine release and turnover in rat brain.
Fukuchi I; Asahi T; Kawashima K; Kawashima Y; Yamamura M; Matsuoka Y; Kinoshita K
Arzneimittelforschung; 1998 Apr; 48(4):353-9. PubMed ID: 9608876
[TBL] [Abstract][Full Text] [Related]
5. Effect of rovatirelin, a novel thyrotropin-releasing hormone analog, on the central noradrenergic system.
Ijiro T; Nakamura K; Ogata M; Inada H; Kiguchi S; Maruyama K; Nabekura J; Kobayashi M; Ishibashi H
Eur J Pharmacol; 2015 Aug; 761():413-22. PubMed ID: 26142830
[TBL] [Abstract][Full Text] [Related]
6. Effects of the novel thyrotropin-releasing hormone analogue Na -((1S,2R)-2-methyl-4-oxocyclopentylcarbonyl)-L-histidyl-L-prol ina mide monohydrate on the central nervous system in mice and rats.
Matsushita M; Yonemori F; Furukawa N; Ohta A; Toide K; Uchida I; Iwata K
Arzneimittelforschung; 1993 Aug; 43(8):813-7. PubMed ID: 8216433
[TBL] [Abstract][Full Text] [Related]
7. Pharmacokinetics of the new thyrotropin releasing hormone analogue montirelin hydrate. 3rd communication: identification of metabolites in rat urine.
Sugimoto T; Hayashi T; Okita A; Morino A
Arzneimittelforschung; 1996 Feb; 46(2):127-33. PubMed ID: 8720300
[TBL] [Abstract][Full Text] [Related]
8. Comparison of TRH and its analog (NS-3) in thermoregulatory and cardiovascular effects.
Huang XC; Saigusa T; Iriki M
Peptides; 1992; 13(2):305-11. PubMed ID: 1409009
[TBL] [Abstract][Full Text] [Related]
9. Effects of thyrotropin-releasing hormone and its analogue, NS-3, on blood pressure, heart rate, and serum catecholamine levels in rats.
Shinozuka K; Shimoura K; Hattori K
Gen Pharmacol; 1997 Feb; 28(2):209-14. PubMed ID: 9013196
[TBL] [Abstract][Full Text] [Related]
10. Autoreceptor-mediated inhibition of norepinephrine release in rat medial prefrontal cortex is maintained after chronic desipramine treatment.
Garcia AS; Barrera G; Burke TF; Ma S; Hensler JG; Morilak DA
J Neurochem; 2004 Nov; 91(3):683-93. PubMed ID: 15485498
[TBL] [Abstract][Full Text] [Related]
11. Bradykinin B2-receptor-mediated stimulation of exocytotic noradrenaline release from cardiac sympathetic neurons.
Kurz T; Tölg R; Richardt G
J Mol Cell Cardiol; 1997 Sep; 29(9):2561-9. PubMed ID: 9299378
[TBL] [Abstract][Full Text] [Related]
12. Co-release of noradrenaline and dopamine in the prefrontal cortex after acute morphine and during morphine withdrawal.
Devoto P; Flore G; Pira L; Diana M; Gessa GL
Psychopharmacology (Berl); 2002 Mar; 160(2):220-4. PubMed ID: 11875641
[TBL] [Abstract][Full Text] [Related]
13. Differences in the mechanisms that increase noradrenaline efflux after administration of d-amphetamine: a dual-probe microdialysis study in rat frontal cortex and hypothalamus.
Géranton SM; Heal DJ; Stanford SC
Br J Pharmacol; 2003 Aug; 139(8):1441-8. PubMed ID: 12922931
[TBL] [Abstract][Full Text] [Related]
14. High-sensitive liquid chromatographic method for determination of neuronal release of serotonin, noradrenaline and dopamine monitored by microdialysis in the rat prefrontal cortex.
Yoshitake T; Yoshitake S; Fujino K; Nohta H; Yamaguchi M; Kehr J
J Neurosci Methods; 2004 Dec; 140(1-2):163-8. PubMed ID: 15589346
[TBL] [Abstract][Full Text] [Related]
15. Enhancement of brain noradrenaline and dopamine turnover by thyrotropin-releasing hormone and its analogue NS-3 in mice and rats.
Itoh Y; Yamazaki A; Ukai Y; Yoshikuni Y; Kimura K
Pharmacol Toxicol; 1996 Jun; 78(6):421-8. PubMed ID: 8829205
[TBL] [Abstract][Full Text] [Related]
16. NS-3 (CG3703), an analog of thyrotropin-releasing hormone, ameliorates cognitive impairment in rats.
Ogasawara T; Ukai Y; Tamura M; Kimura K
Pharmacol Biochem Behav; 1995 Apr; 50(4):499-503. PubMed ID: 7617693
[TBL] [Abstract][Full Text] [Related]
17. NS-3(CG3703), a TRH analog, ameliorates scopolamine-induced memory disruption in rats.
Ogasawara T; Nakagawa Y; Ukai Y; Tamura M; Kimura K
Pharmacol Biochem Behav; 1995 Aug; 51(4):929-34. PubMed ID: 7675879
[TBL] [Abstract][Full Text] [Related]
18. Evidence for interplay between thyrotropin-releasing hormone (TRH) and its structural analogue pGlu-Glu-Pro-NH2 ([Glu2]TRH) in the brain: an in vivo microdialysis study.
Nguyen V; Zharikova AD; Prokai L
Neurosci Lett; 2007 Mar; 415(1):64-7. PubMed ID: 17234338
[TBL] [Abstract][Full Text] [Related]
19. Lack of behavioral tolerance by repeated treatment with taltirelin hydrate, a thyrotropin-releasing hormone analog, in rats.
Asai H; Asahi T; Yamamura M; Yamauchi-Kohno R; Saito A
Pharmacol Biochem Behav; 2005 Dec; 82(4):646-51. PubMed ID: 16368129
[TBL] [Abstract][Full Text] [Related]
20. Characterization of in vivo noradrenaline release from superior cervical ganglia or fetal locus coeruleus transplanted to the subcortically deafferented hippocampus in the rat.
Cenci MA; Nilsson OG; Kalén P; Björklund A
Exp Neurol; 1993 Jul; 122(1):73-87. PubMed ID: 8339791
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
